Fundamentals of the psoralen-based Helinx[trade ] technology for inactivation of infectious pathogens and leukocytes in platelets and plasma
- 1 October 2001
- journal article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 38 (4, Suppl 1), 4-11
- https://doi.org/10.1053/shem.2001.29495